THE NEW POSSIBILITY FOR PHYSIQUE MANAGEMENT ?

Experts are rapidly examining retatrutide, a novel medication created by Eli Lilly, as a possible advance in weight management. Distinct from many previous approaches, retatrutide is a twin-action compound targeting equally GLP-1 and GIP, hormones that influence satiety and blood sugar balance.